/

Ultragenyx

Developing and commercializing therapies for rare genetic diseases.

BiotechnologyPharmaceuticals ultragenyx.com ↗

Company facts

Founded: 2010
Employees: 1,371
Headquarters: United States
Type: Public
Listed: NASDAQ: RARE
Subsidiaries: Dimension Therapeutics, GeneTx Biotherapeutics